Viewing Study NCT03671460


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-02-21 @ 6:44 PM
Study NCT ID: NCT03671460
Status: UNKNOWN
Last Update Posted: 2018-09-14
First Post: 2018-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.
Sponsor: Tianjin Mycure Medical Technology Co., Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell acute lymphoblastic leukemia View
None CD19 CAR-T View